Rabbit neutrophils were stimulated with the chemotactic peptide fMet-Leu-Phe in the presence of the methyltransferase inhibitors homocysteine (HCYS) and 3-deazaadenosine (3-DZA) . HCYS and 3-DZA inhibited chemotaxis, phospholipid methylation, and protein carboxymethylation in a dose-dependent manner . The chemotactic peptide-stimulated release of [t "C]arachidonic acid previously incorporated into phospholipid was also partially blocked by the methyltransferase inhibitors . Stimulation by fMet-Leu-Phe or the calcium ionophore A23187 caused release of arachidonic acid but not of previously incorporated ['"C]-labeled linoleic, oleic, or stearic acids. Unlike the arachidonic acid release caused by fMet-Leu-Phe, release stimulated by the ionophore could not be inhibited by HCYS and 3-DZA, suggesting that the release was caused by a different mechanism or by stimulating a step after methylation in the pathway from receptor activation to arachidonic acid release. Extracellular calcium was required for arachidonic acid release, and methyltransferase inhibitors were found to partially inhibit chemotactic peptide-stimulated calcium influx . These results suggest that methylation pathways may be associated with the chemotactic peptide receptor stimulation of calcium influx and activation of a phospholipase A2 specific for cleaving arachidonic acid from phospholipids .
Leukocytes respond with a directed migratory movement, chemotaxis, to a number of peptides derived from complement (1) , crude bacterial factors (2) , and well-defined synthetic formylated peptides (3, 4) . The chemotactic response to the formylated peptides involves interaction with specific receptors on the cell surface (5) . However, the biochemical events translating receptor activation into directed cell movement remain poorly understood . It has been shown in this and other laboratories that some early events in chemotactic peptide-stimulated cell movement are: activation of protein carboxy-o-methylase (6) , degradation of phosphatidylcholine synthesized by transmethylation of phosphatidylethanolamine (7) , release of arachidonic acid (7, 8) which can be metabolized to hydroxyeicosatetraenoic acids that are also chemoattractants (9, 10) and influx and redistribution of calcium ions (11, 12, 13) . Inhibition of any one of these processes inhibits receptoractivated neutrophil chemotaxis (7, 14, 15, 16, 17, 18) . However, little is known about the interrelationships between peptide receptor, methyltransferase reactions, calcium ion fluxes, and phospholipase A2 activation leading to induced neutrophil 690 migration . Studies on other receptor-mediated stimulations of T lymphocytes, mast cells, and rat basophilic leukemia cells have suggested that phospholipid methylation is involved in calcium ion movement, activation of phospholipase A 2 , and the specific cellular response (19, 20, 21) . We report here that methyltransferase inhibitors partially block receptor-mediated calcium influx, phospholipase A2 activation, and chemotaxis in rabbit neutrophils . Furthermore the chemotactic peptide fMet-Leu-Phe and the calcium ionophore A23187 specifically stimulate the release of arachidonic acid and no other fatty acid examined.
MATERIALS AND METHODS

Cell Preparations
Rabbit leukocytes were obtained by lavage of the peritoneal cavity of rabbits injected 8 to 12 h earlier with 150 ml of 0.1% glycogen (4) . After collection by centrifugation at 600 g for 10 min, the cells were suspended in Gey's balanced salt solution containing 1% essentially fatty acid-free bovine serum albumin (BSA) (to maintain chemotactic responsiveness) and 0.015 M HEPES buffer at pH 7.4 (Gey's buffer). BSA in the media was essential to maintain chemotactic responsiveness and for reproducible results. A typical cell preparation contained 90% neutrophils and 10% lymphocytes and macrophages . Chemotaxis was measured in modified Boyden chambers as described (1) using 1 nM fmet-Leu-Phe as the chemoattractant and incubating the chambers for 2 h at 37°C .
Assays of Phospholipid Methylation and Protein Carboxymethylation
Intact leukocytes at a concentration of 15 x 106 cells/ml in Gey's buffer were incubated with 10 pct L-[methyl-'H]methionine in small plastic tubes for l h at 37°C. Each tube contained 0.2 ml of cell suspension with or without additions. The reaction was stopped by the addition of 0.5 ml of 10% wt/vol trichloroacetic acid (TCA) containing I mM unlabeled methionine . After centrifugation at 27,000 gfor 10 min, thepellets were extracted with 3 ml of chloroform/methanol, 2/1 (vol/vol) fordetermination of phospholipid methylation (19, 22) . For protein carboxymethylation, the TCA-precipitated protein carboxymethylesters were hydrolyzed for 30 min with l ml of 1.0 M borate buffer at pH 11 containing unlabeled methanol 1% vol/vol as carrier, and the hydrolytic product, ['H]methanol, was extracted with 3 ml of a 3/2 mixture (vol/vol) of toluene and isoamyl alcohol as previously described (6, 23) .
Fatty Acid Incorporation and Release
Leukocytes (10 x 106 cells/ml)were preincubated for 30 min at 37°C in Gey's buffer with 4.4 pct [I-"C]arachidonic acid, [1-"C]-stearic acid, [1-"C]oleic acid or (1-"C]linoleic acid in a final concentration of 0.5% vol/vol ethanol which was used to suspendthe fatty acids. The cells were then washed twiceand resuspended in Gey's buffer . Under these conditions of preincubation, arachidonic acid may be metabolized to products which increase neutrophil calcium permeability (24); however, no degranulation occurred and, after washing, the cells retained their responses to fMet-Leu-Phe . For experiments using homocysteine thiolactone and/or 3-deazaadenosine, these labeled cells were then incubated for 30 min at 37°C with or without the inhibitors, centrifuged, and the pelletswere resuspended in Gey's buffer with or without the drugs. Each tube contained 0.5 ml of cell suspension (5 x 106 cells) . The reaction was started by the addition of 10 nM fMet-Leu-Phe, a concentration which produces maximal stimulation of both chemotaxis and arachidonic acid release (4, 7) , and stopped by the addition of 1 ml of cold Gey's buffer. After centrifugation at 6,000 g for 10 min, 0.5 ml of supernatant was counted with a liquid scintillation spectrometer for the release of ['"C] fatty acid. To identify the released radioactive products after ["Clarachidonic acid incorporation, an additional 0.5 ml of supernatant was acidified to pH 3 with IN formic acid, extracted with 6 vol of ethyl acetate, and chromatographed on a silica gel G plate developed in the upper phase of ethyl acetate/2,2,4-trimethylpentane/glacial acetic acid/water (90/50/20/100). This solvent system separates hydroxyeicosatetraenoic acids (HEPES) from the prostaglandin products of arachidonic acid (l0, 25). To measure the incorporation of ["C]arachidonic and other fatty acids into phospholipids, the pellet obtained after centrifugation was suspended in 0.5 ml of 10% (wt/vol) TCA, centrifuged at 27,000 g for 10 min, and extracted with chloroform/methanol as described above. The separation and identification of phospholipids was carried out by thin-layer chromatography (TLC) of the washed chloroform phase (dehydrated overnight with anhydrous sodium sulfate and evaporated under a stream of N2 gas) on a silica gel G plate developed in chloroform/methanol/water (65/25/4; vol/vol) (26) . Thin-layer chromatograms were scanned for radioactivity using a BID System 100 radiochromatogram imaging system (Bioscan, Inc., Washington, D.C .) .
Calcium Flux
Leukocytes at a concentration of 5 x 106 cells/ml in Gey's buffer (including 1 mM CaC12 ) were preincubated for 30 min at 37°C with 10 trCi/ml°5CaC12 with or without homocysteine thiolactone and 3-deazaadenosine (14) . The incubation was then continued in the presence or absence of 10 nM fMet-Leu-Phe. Each tube contained 0.5 ml (2.5 x 106 cells) and the flux was stopped with theaddition of 0.75 ml of ice-cold 0.9% NaCl containing 5 mM CaC12 and 10 mM HEPES (pH 7.4). Thecells were immediately centrifuged for 30 s in aBeckman Microfuge B (Beckman Instruments, Inc., Fullerton, CA) andresuspended andwashed twice with ice-cold saline-CaC12-HEPES . The cells were then lysed by resuspension in 5 mM CaC1 2, the membranes were centrifuged at 20,000 g for 10 min, and the supernatant was counted by liquid scintillation spectrometry.
Data Presentation
Because of large variations in the day-to-day response to fmet-Leu-Phe of different preparations of rabbit neutrophils, the figures and tables shown here generally represent means of two to three determinations from a single typical experiment . Standard error of the mean (SEM) of replicate values did not exceed 10%. The number of experiments performed and range of amount of stimulation and/or inhibition found are given in legends . 
Materials
RESULTS
Inhibition of Methyltransferases and Chemotaxis
Previous work has shown that inhibitors of methyltransferases block chemotactic processes in a number of eucaryotic cells, including neutrophils, monocytes and macrophages (17, 27, 28, 29) . Both protein carboxy-o-methylation and phospholipid methylation have been implicated in chemotactic peptidestimulated movement in neutrophils (6, 7, 17, 30) . To determine whether protein carboxymethylation and/or phospholipid methylation are involved in the directed movement of rabbit neutrophils induced by the peptide Met-Leu-Phe, various concentrations of 3-deazaadenosine (3-DZA) and homocysteine (HCYS) were used to selectively inhibit the different methyltransferases. Incubation of cells with 3-DZA and HCYS leads to the accumulation of s-adenosylhomocysteine and 3deazaadenosylhomocysteine which then results in the inhibition of s-adenosylmethionine-requiring methyltransferases (31, 32) . HYCS and 3-DZA inhibited both phospholipid methylation and protein carboxymethylation to about the same extent in a dose-dependent manner ( Fig. 1 ) . fMet-Leu-Phe-induced chemotaxis was also reduced by the methyltransferase inhibitors in the same dose range, possibly implicating one or both of these methylation reactions in chemotaxis . HCYS potentiates the inhibition by 3-DZA, particularly at low 3-DZA concentrations, and maximal inhibition of phospholipid methylation (85-90% inhibited) was obtained using 1 mM HCYS and 0 .1 mM 3-DZA; these were the concentrations used in subsequent experiments on fMet-Leu-Phe-stimulated arachidonic acid release and calcium flux. Very little inhibition of nucleic acid methylation could be demonstrated at the concentrations found to inhibit phospholipid methylation, protein carboxymethylation, and chemotaxis (data not shown) .
Phospholipid Methylation and Phospholipase A 2 Activation
Recent work in our laboratory has shown that stimulation of rabbit neutrophils by chemotactic peptides produces a receptormediated activation of phospholipase A2 as shown by the release of arachidonic acid previously incorporated into phospholipids (7) . In rat basophilic leukemia cells, it has been found that the receptor-mediated increase in phospholipid methylation is associated with phospholipase A2 activation and histamine release (21) . To determine whether phospholipid methylation is associated with phospholipase A2 activation and subsequent release of arachidonic acid, neutrophils were prelabeled by incubation with [t"Clarachidonic acid . This fatty acid is known to be preferentially incorporated into the CHEMOTAXIS ___-0 001 1 10 100 1000
Dose response curves for inhibition of fMet-Leu-Phestimulated chemotaxis, phospholipid methylation, and protein carboxymethylation by 3-deazaadenosine in rabbit neutrophils . Chemotaxis incubations were done for 2 h at 37°C in modified Boyden chambers containing 2 x 106 cells and 1 nM fMet-Leu-Phe and were performed after 30-min preincubation with various concentrations of 3-deazaadenosine and 1 gM homocysteine thiolactone (HCYS) . Chemotaxis results are expressed as means of duplicate determinations from two experiments . Methyltransferase assays were incubated for 1 h at 37°C without chemoattractant . Methylation data are expressed as means of duplicate determinations which did not vary by >5%; the experiment was performed three times . Blanks for methyltransferase reactions were kept at 0°C and were <15% of uninhibited samples incubated at 37°C . Abscissa is logarithmic .
2-position of the glycerol moiety of phospholipids . After a 30min incubation with labeled fatty acid, the lipids were extracted as described in Materials and Methods and separated by TLC ( Fig . 2) . Most of the [ I4 C]arachidonic acid was incorporated into phosphatidylcholine ; a smaller amount was present in phosphatidylethanolamine and a negligible amount of [ I4 C]arachidonic acid was found in phosphatidylinositol or phosphatidylserine. The remainder of the radioactivity migrated 69 2 THE JOURNAL OF CELL BIOLOGY " VOLUME 93, 1982 with nonpolar lipids. Stimulation with fMet-Leu-Phe caused a release of radioactivity from rabbit neutrophils . >9001o of the radioactivity comigrated with arachidonic acid on thin-layer chromatography to separate arachidonic acid metabolites (data not shown), suggesting that these compounds (mostly HETEs) are reincorporated into the cell as previously reported (10) . To examine the effect of inhibition of methyltransferase reactions on peptide-induced release of arachidonic acid, cells were incubated for 30 min at 37°C with [ Ia C]arachidonic acid, then washed and incubated for an additional 30 min with HCYS and 3-DZA . The subsequent stimulation of the cells with fMet-Leu-Phe resulted in -60% inhibition of arachidonic acid release as compared to cells incubated without methyltransferase inhibitors (Fig. 3 ) . This inhibition of release of arachidonic acid by methyltransferase inhibitors was found to be concentration-dependent ( Fig . 4 ) . The methyltransferase inhibitors had no effect on unstimulated release of [ I4 C]arachidonic acid (data in Table V, line 1) or on viability of the cells as measured by trypan blue staining. These results suggest that the arachidonic acid released by the chemotactic peptide may partially arise from phospholipids synthesized by the methylation pathway .
Specificity of Wet-Leu-Phe-Stimulated Fatty Acid Release
Several recent studies have suggested that different compartments of phospholipases A 2 may exist which are either closely coupled to receptor activation or respond to more general stimulation (33) (34) (35) (36) . In mouse fibroblasts and rat leukemic basophils, receptor-mediated activation of phospholipase A2 specifically releases arachidonic acid from phospholipids, while stimulation with the calcium ionophore A23187 results in the nonspecific release of several different fatty acids (35, 37) . To determine whether the phospholipase activated by the chemotactic peptide, fMet-Leu-Phe, selectively releases arachidonic acid, neutrophils were prelabeled by incubation for 30 Abscissa is logarithmic . f 1a C]oleic or [ 14 C]stearic acid. Under these conditions a similar amount of each fatty acid was incorporated into lipid, and after extraction and separation by TLC a considerable portion of the fatty acid was found to be incorporated into phosphatidylcholine (Table I) . However, upon stimulation with either fMet-Leu-Phe or A23187 or both, only arachidonic acid was released to any appreciable extent (Table II) . A23187 also released -10fold less linoleic acid. Either stimulant appeared able to stabilize oleic acid-containing lipids, inhibiting its release . It would appear that in rabbit neutrophils both the receptor-activated phospholipase A2 and the enzyme stimulated by increased calcium flux caused by the ionophore are quite specific for the release of arachidonic acid.
Phospholipid Methylation, Calcium Influx, and Arachidonic Acid Release Several studies have demonstrated a requirement for calcium fluxes in neutrophil chemotaxis measured in Boyden chambers (14, 15, 38, 39) . Treatment of rabbit neutrophils with fMet-Leu-Phe stimulates calcium influx (I1-13), and this ion has also been found to activate phospholipase A2 (40) (41) (42) (43) . To determine whether extracellular calcium is required for stimulation of arachidonic acid release by the chemotactic peptide, rabbit neutrophils were incubated with or without calcium or without calcium and including EDTA (Table III ) . In the absence of calcium there was negligible release of arachidonic acid after treatment with fMet-Leu-Phe .
We have shown that the methylation of phospholipids en- hances calcium flux in IgE receptor-mediated release of histamine from mast cells and rat basophilic leukemia cells (20, 37) . This prompted an examination of the effect of inhibition of methylation on the 75% increase in intracellular calcium measured after treatment with Met-Leu-Phe. Rabbit neutrophils were pretreated with methyltransferase inhibitors and the effect of these compounds on stimulated calcium movement was measured . HCYS and 3-DZA had no effect on unstimulated equilibration of 'Ca in the cells . However, the methyltransferase inhibitors blocked the influx of "Ca by -40% (Fig. 5 ) . Inhibition of fet-Leu-Phe-stimulated 45 Ca movement was seen at 3-DZA concentrations as low as 10 uM (Table IV) . These results implicate phospholipid and/or protein carboxymethylation in the partial regulation of calcium movements stimulated by fet-Leu-Phe . It should be noted that the net calcium movement measured included both intracellular displacement from membrane binding sites and the opening of calcium channels to increase membrane permeability to the ion . Methyltransferase inhibitors would not be expected to interfere with all the processes measured using our procedure and therefore the 40% inhibition obtained can be regarded as quite substantial. As shown above, methyltransferase inhibitors partially prevented the chemotactic peptide-stimulated calcium influx and arachidonic acid release, thus implicating methylation as one factor involved in receptor stimulation of both processes . We then tested the effect of HCYS and 3-DZA on arachidonic acid release caused by direct stimulation of calcium fluxes using the ionophore A23187 (Table V) . While the addition of methyltransferase inhibitors considerably reduced the effect of the chemotactic peptide, there was no effect on the release of arachidonic acid by the ionophore . This suggests that direct stimulation of calcium fluxes by the ionophore bypasses any requirement for the methyltransferase enzymes .
The results presented here suggest that peptide receptor-mediated chemotaxis may involve phospholipid methylation, calcium influx, and arachidonic acid release, and these processes appear to be associated in a cascade of events required for activation of directed movement in rabbit neutrophils. Our findings are consistent with a sequence in which receptor activation is followed by phospholipid methylation (or protein carboxymethylation as discussed below) which stimulates the influx or membrane redistribution of calcium ions, and increased calcium availability leads to the activation of phospholipase A2, an enzyme generating arachidonic acid from phospholipids. Other studies have shown that released arachidonic acid is metabolized by a lipoxygenase to products which are reincorporated into the cell (10, 44) and this metabolism may be essential for chemotaxis (16, 18) . A similar cascade has also been found for other receptor-mediated processes, notably IgE stimulation of histamine release from rat mast cells and basophilic leukemia cells (20, 21, 37) and concanavalin A stimulation of T-lymphocyte mitogenesis (45) .
Specifically, we have shown that inhibition of methyltransferase reactions by homocysteine and 3-deazaadenosine also inhibits Met-Leu-Phe stimulation of calcium movement, arachidonic acid release, and chemotaxis . Furthermore, increasing the calcium availability directly by using the calcium ionophore A23187 activates a phospholipase with the same specificity for arachidonic acid as the enzyme stimulated by fet-Leu-Phe . These data suggest that methyltransferase reactions precede and are required for normal levels of chemotactic factor-stimulated calcium flux and arachidonic acid release, and it may be the increased calcium availability which then activates arachidonic acid release. Since methyltransferase inhibitors do not block calcium ionophore-stimulated arachidonic acid release, it may be that methylation is not directly required for phospholipase activation but is involved in the calcium redistribution required to release arachidonic acid . However, it has been shown that arachidonic acid released by fMet-Leu-Phe stimulation at least partially arises from increased degradation of phospholipids synthesized through the methylation pathway (7) . Therefore phospholipid methylation may also provide a substrate for activated phospholipase A 2 in addition to stimulating calcium availability . Previous work in this and other laboratories has indicated that each of the biochemical events studied here could be required for neutrophil chemotaxis, but the sequence of these processes is probably much more complicated than our data alone would seem to suggest . Inhibition of methyltransferases inhibits chemotaxis in several eucaryotes (17, (27) (28) (29) . Calcium fluxes have been demonstrated to be necessary for efficient neutrophil chemotaxis in Boyden chambers (14, 15, 38, 39) , while mepacrine, an inhibitor of phospholipase A2 (46) (47) (48) (49) (50) , decreases both arachidonic acid release and chemotaxis over the same dose range (7) . Calcium is required for stimulation of phospholipase A 2 in this and other systems (40) (41) (42) (43) . However, there is also evidence that arachidonic acid metabolites increase membrane permeability to calcium, causing increased calcium influx (24) . Since calcium movement stimulated by fMet-Leu-Phe occurs faster than the flux stimulated by arachidonic acid (11, 24) , more than one mechanism may be involved. The very rapid influx in the first 2-5 min seen with fMet-Leu-Phe may in fact be due to release of calcium from a membrane-bound pool to the cytoplasmic side of the membrane (12). This calcium could activate phospholipase A2, releasing arachidonic acid, whose metabolites then cause the plasma membrane to become more permeable to calcium ions. This process could account for fMet-Leu-Phe-stimulated increases in intracellular "Ca2+ content after 5 min . While the first phase (redistribution of calcium from the membrane) may activate phospholipases, the second phase (permeability increase) may be essential for other calcium requiring events in neutrophil function, such as microtubule assembly and lysosomal enzyme release . Our assay for calcium movement counted only the nonmembrane bound intracellular "Ca" content and can not differentiate between increased influx and membrane redistribution . Clearly, much more work needs to be done on the biochemistry of fMet-Leu-Phe-stimulated calcium mobilization and arachidonic acid release and metabolism to unambiguously determine the sequence of these events during activation of chemotaxis .
It is not clear how methylation of phospholipids or proteins can stimulate calcium movement . One possibility is that phospholipid methylation changes the local lipid environment around the calcium channel or binding site, increasing fluidity and allowing calcium to be released or the channel to open . A decrease in membrane viscosity measured with fluorescent and spin-labeled probes has been associated with phospholipid methylation in erythrocytes (22, 51) . This fall in viscosity may allow mobility of membrane proteins . Alternatively, calcium binding sites on membrane proteins may be carboxymethylated . Although methyltransferase inhibitors only partially block chemotactic factor-stimulated calcium mobilization, this may be sufficient to reduce calcium availability below the critical level needed for phospholipase A2 activation. Also, degradation of methylated phospholipids to release arachidonic acid may be further hampered by lower availability of substrate in the presence of methyltransferase inhibitors .
The demonstration that chemotactic factors enhance arachidonic acid release by specifically stimulating the degradation of phosphatidylcholine synthesized from the methylation pathway and not the CDP-choline pathway (7) suggests that phospholipid methylation may be the methyltransferase reaction of most interest in understanding receptor activation of neutrophil chemotaxis . However, in these studies the methyltransferase inhibitors were used in concentrations that inhibited protein carboxymethylation as well as phospholipid methylation . Protein carboxymethylation has been shown to be essential for bacterial chemotaxis (52, 53) and in neutrophils can be transiently stimulated by the chemotactic peptide fMet-Leu-Phe (6) . The experiments presented here do not rule out the possibility that protein carboxymethylation plays a role in chemotactic factor receptor activation of calcium mobilization and phospholipase A2 . It is possible that both methyltransferases are involved in the complex series of events leading to directed movement of neutrophils. Chemotactic factor-induced arachidonic acid release was less sensitive than phospholipid methylation, protein carboxymethylation, calcium mobilization, or chemotaxis to inhibition by low concentrations of homocysteine and 3-deazaadenosine . This may have resulted from any one or a combination of several factors . First, as discussed above, methylation of phospholipids or proteins may be only indirectly linked to phospholipase A2 activation by either increasing calcium availability or providing a substrate for degradation by the phospholipase . Second, arachidonic acid undoubtedly arises from sources other than methylated phospholipids, such as a small pool of phosphatidylinositol . Rapid turnover of this lipid is also stimulated by fMet-Leu-Phe ; however, in neutrophils this has not been associated with either chemotaxis or lysosomal enzyme release (54, 55) . Another problem arises when considering the limitations of our measurement of arachidonic acid release . Only extracellular arachidonic acid was counted in our assay, and >90% of that was found not to be metabolized. The arachidonic acid released by fMet-Leu-Phe stimulation is known to be further metabolized by lipoxygenase to leukotrienes and by cyclooxygenase to prostaglandins (44) . These metabolites are then taken up by the neutrophil and reincorporated into cellular lipids (10) . Therefore, the measured extracellular arachidonic acid does not include the reincorporated metabolites produced, and probably underestimates the total amount of arachidonic acid released. Since the metabolized pool is probably most closely associated with receptor-stimulated release, production of arachidonic acid metabolites upon fMet-Leu-Phe stimulation may prove to be more sensitive to blockade by methyltransferase inhibitors than the release of untransformed arachidonic acid . Metabolites of the lipoxygenase pathway such as hydroxyeicosatetraenoic acids (HETEs) and, more recently, the leukotrienes have been shown to possess potent chemotactic activity (8, 56, 57) . Inhibition of lipoxygenase and cyclooxygenase with eicosatetraynoic acid (ETYA) or nordihydroguaiaretic acid inhibits chemotaxis (16, 18) . Prostaglandin E, though not itself a strong chemoattractant, has been implicated as a possible modulator of the chemotactic potency of the lipoxygenase products (58) .
Arachidonic acid was the only fatty acid released by stimulation with either fMet-Leu-Phe or A23187 . While other receptor-mediated activations of phospholipases have demonstrated similar fatty acid specificity (34-36), A23187 stimulation has BAREIS ET AL.
Phospholipid Metabolism and Neutrophil Chemotaxis generally resulted in nonspecific release of several fatty acids in these systems, suggesting the presence and activation of several phospholipase A2 compartments (34, 37) . In the rabbit neutrophil, however, the specificity for arachidonic acid release suggests that fet-Leu-Phe and A231ß7 may be activating the same pool of phospholipases . In neutrophils, it appears that the calcium-activated membrane phospholipases are specific for arachidonic acid-containing phospholipid . However, specificity for one fatty acid does not necessarily have to arise from chemical specificity of the enzyme but may be due to topological localization within the membrane. In our proposed model for receptor-activated arachidonic acid release, the receptor, phospholipid methyltransferases, calcium channel or binding site, phospholipase A2, and perhaps also a reacylase could be closely associated in a cluster within the membrane. In rat basophilic leukemia cells, phosphatidylcholine rich in arachidonic acid arises from the methylation pathway which supplies the phospholipids for metabolism by a phospholipase A2 stimulated by IgE and presumably located nearby (37) .
In conclusion, the data presented here suggest that several processes which have previously been implicated in neutrophil chemotaxis may be associated in a sequence starting with activation of the chemotactic receptor and eventually resulting in directed movement. Methylation of phospholipids or proteins or both appears to be an early event in the sequence because methyltransferase inhibitors also partially block fMet-Leu-Phe-stimulated calcium movement, arachidonic acid release, and chemotaxis . Increased calcium availability may be the event which activates phospholipase A2 to release arachidonic acid from methylated phospholipids, since stimulation by calcium ionophore A231ß7 alone also causes specific release of arachidonic acid. However, this association between the chemotactic factor receptor, methyltransferase enzymes, calcium mobilization, phospholipase A2 , and chemotaxis does not appear to be absolute, and future investigations are needed to further define the relationship between these events .
